ClinicalTrials.gg
CompletedNCT07734662Updated Jul 29, 2026

High-Intensity vs. Preferred-Intensity Resistance Training in Fibromyalgia

An interventional study of Preferred-Intensity Resistance Training Group (PIG) and High-Intensity Resistance Training Group (HIG) in Fibromyalgia, sponsored by University of the State of Santa Catarina. Completed at 1 site in Brazil. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-29.

Sponsored by University of the State of Santa Catarina · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled Jul 2024, registered Jul 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 60 studies in Fibromyalgia with a site in Brazil — 6 open to participants now, 8 under way, none of them phase 3. Fibromyalgia · Brazil.

Enrollment
44th of 58
36 · median 60
Started
2024
with 2 others
No phase
39 of 60
4 open now
Registered
58th of 60
by date

Among the 60 studies in Fibromyalgia with a site in Brazil, this one is the 44th largest by enrollment of the 58 interventional ones that give a count, is one of 3 that started in 2024, is one of 39 with no phase, and was the 58th registered.

Fibromyalgia

1,245 studies on the registry are indexed under Fibromyalgia; 256 are open to participants now.

Browse Fibromyalgia studies →

Open to participants now

6 of the 60 studies in Fibromyalgia with a site in Brazil are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 161 Fibromyalgia studies recruiting now, 51 (32%) set no upper age limit and 96 (60%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 60 studies in Fibromyalgia with a site in Brazil, or all of them as a file.
02

Study summary

This randomized crossover clinical trial aims to verify and compare the effects of high-intensity (HIG) and preferred-intensity (PIG) resistance training on the health of women with fibromyalgia (FM). Secondary objectives include verifying differences after 4, 8, and 16 sessions, as well as evaluating the proportion of participants who achieve the minimal clinically important difference in the disease impact/severity outcome.

Patients included in the study will be randomized into two groups: HIG and PIG. Sixteen training sessions will be conducted twice a week, with each session lasting approximately 60 minutes. Subsequently, patients will undergo a minimum 8-week washout period (detraining) and will then be allocated to the other intervention group.

The primary outcome is disease impact evaluated using the Revised Fibromyalgia Impact Questionnaire (FIQR). Secondary outcomes include mood states evaluated by the Brunel Mood Scale (BRUMS), sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI), anxiety levels evaluated with the Beck Anxiety Inventory (BAI), and depression levels evaluated with the Beck Depression Inventory (BDI). Attendance and absence data will also be collected, as well as information regarding program discontinuation.

03

Conditions studied

  • Fibromyalgia

Keywords

  • Mental Health
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Provision of signed to participate in the study.
  • Female participants aged 18 years or older.
  • Confirmed clinical diagnosis of fibromyalgia documented by a medical report.
  • Not currently participating in any regular physical activity involving strength or resistance training.

Exclusion criteria

Exclusion Criteria:

  • Presence of physical or cognitive conditions that impair the execution of the prescribed exercises.
  • Pregnancy.
  • Medical to physical exercise.
  • Engagement in physical activities such as resistance training, Pilates, swimming, calisthenics, yoga, or martial arts.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    High-intensity resistance training(HIG)

    Participants complete an 8-week supervised resistance training program consisting of 2 weekly 60-minute sessions (up to 16 sessions total, with flexibility to reschedule missed sessions due to clinical reasons). Sessions take place in an academic exercise facility under the supervision of qualified physical therapists, exercise physiologists, or trained undergraduate students. Temporary adaptations (e.g., load reduction, modified range of motion, bench angle adjustments, or box squats) are applied as needed for fibromyalgia symptoms to support progression toward standard execution. Adverse events, attendance, and reasons for missed sessions or dropouts are systematically monitored and recorded. Dosage: 4 sets of 6 repetitions with 2 minutes of rest between sets. Participants are encouraged to reach concentric failure on the last set. Load: Load increases by 10% to 20% after proper execution for two consecutive sessions, under supervisor guidance.

    Device: High-Intensity Resistance Training Group (HIG)

  • Experimental
    Preferred-intensity resistance training (PIG)

    Participants complete an 8-week supervised resistance training program consisting of 2 weekly 60-minute sessions (up to 16 sessions total, with flexibility to reschedule missed sessions due to clinical reasons). Sessions take place in an academic exercise facility under the supervision of qualified physical therapists, exercise physiologists, or trained undergraduate students. Temporary adaptations (e.g., load reduction, modified range of motion, bench angle adjustments, or box squats) are applied as needed for fibromyalgia symptoms to support progression toward standard execution. Adverse events, attendance, and reasons for missed sessions or dropouts are systematically monitored and recorded. Dosage: 3 sets of 8-12 repetitions with 1 to 2 minutes of rest between sets. Load : Participants self-select the load based on their perceived capacity, with the suggestion that it could lead to concentric failure. Load increases when the participant executes the movement correctly and requests

    Device: Preferred-Intensity Resistance Training Group (PIG)

Interventions

  • DevicePreferred-Intensity Resistance Training Group (PIG)

    Participants complete an 8-week supervised resistance training program consisting of 2 weekly 60-minute sessions (up to 16 sessions total, with flexibility to reschedule missed sessions due to clinical reasons). Prior to the intervention, participants complete 3 familiarization sessions without intensity control to learn proper exercise execution and facility equipment. Each session includes a low-load warm-up (1 lower-body and 2 upper-body exercises), main part of the session (chest press, seated cable row, squat, leg press, shoulder press, and standing calf raise), and 10 minutes of static stretching cooldown. Participants perform 3 sets of 8-12 repetitions with 1-2 minutes of rest between sets. Load selection is based on the participant's perceived capacity, with instructions that the weight may lead to concentric failure. Load progression occurs when exercises are performed with proper technique and the participant requests an increase; all loads are continuously logged.

    Also known as: Exercise

  • DeviceHigh-Intensity Resistance Training Group (HIG)

    Participants complete an 8-week supervised resistance training program consisting of 2 weekly 60-minute sessions (up to 16 sessions total, with flexibility to reschedule missed sessions due to clinical reasons). Prior to the intervention, participants complete 3 familiarization sessions without intensity control to learn proper exercise execution and facility equipment. Each session includes a low-load warm-up (1 lower-body and 2 upper-body exercises), themain part of the sessi (chest press, seated cable row, squat, leg press, shoulder press, and standing calf raise), and 10 minutes of static stretching cooldown. Participants perform 4 sets of 6 repetitions with 2 minutes of rest between sets, encouraged to reach concentric failure on the final set.Load increases by 10%-20% following proper execution across two consecutive sessions; all loads are continuously logged.

    Also known as: Exercise

06

What researchers measure

Primary outcomes

  1. Severity and impact of fibromyalgia

    The Revised Fibromyalgia Impact Questionnaire (FIQR) evaluates the impact of fibromyalgia on patients' quality of life over the preceding 7 days (Lupi et al., 2017). The instrument assesses symptoms and daily difficulties using a 0-to-10 numerical rating scale, where higher scores indicate greater disease impact. The 21-item questionnaire yields a total score ranging from 0 to 100, composed of three subscales: Function (0-30), Overall Impact (0-20), and Symptoms (0-50). Total scores can also be classified into severity categories: 0-23 (remission), 24-40 (mild), 41-63 (moderate), 64-82 (severe), and ≥ 83 (very severe) (Salaffi et al., 2021).

    Time frame: Baseline, 2 weeks (4 sessions), 4 weeks (8 sessions), and 8 weeks (after 16 sessions)

Secondary outcomes

  1. Mood States (BRUMS)

    Assessed using the Brunel Mood Scale (BRUMS), a 24-item questionnaire scored on a 5-point Likert scale from 0 (not at all) to 4 (extremely). It measures six subscales: Tension, Depression, Anger, Vigor, Fatigue, and Confusion. Each subscale score ranges from 0 to 16, with higher scores reflecting greater intensity of the respective mood state.

    Time frame: Baseline, 2 weeks (4 sessions), 4 weeks (8 sessions), and 8 weeks (after 16 sessions)

  2. Sleep Quality (PSQI)

    Assessed using the Pittsburgh Sleep Quality Index (PSQI), which evaluates sleep quality over the past week across seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Global scores range from 0 to 21, where values of five or higher indicate poor quality.

    Time frame: Baseline, 4 weeks (8 sessions), and 8 weeks (after 16 sessions)

  3. Anxiety Levels (BAI)

    Assessed using the Beck Anxiety Inventory (BAI), a 21-item self-report questionnaire. Items are scored on a scale from 0 to 3, yielding a total score ranging from 0 to 63, where higher scores indicate higher levels of anxiety.

    Time frame: Baseline, 2 weeks (4 sessions), 4 weeks (8 sessions), and 8 weeks (after 16 sessions)

  4. Depression Levels (BDI)

    Assessed using the Beck Depression Inventory (BDI), a 21-item self-report questionnaire. Items are scored on a scale from 0 to 3, yielding a total score ranging from 0 to 63, where higher scores indicate higher levels of depressive symptoms.

    Time frame: Baseline, and 8 weeks (after 16 sessions)

07

Study locations

1 site
  • Centro de Ciências da Saúde e do Esporte / Universidade do Estado de Santa Catarina
    Florianópolis, Santa Catarina 88080-350, Brazil
08

References and documents

Publications

  • Vilarino GT, Andreato LV, de Souza LC, Branco JHL, Andrade A. Effects of resistance training on the mental health of patients with fibromyalgia: a systematic review. Clin Rheumatol. 2021 Nov;40(11):4417-4425. doi: 10.1007/s10067-021-05738-z. Epub 2021 May 14. PubMed 33987785 ↗
  • Vilarino GT, Branco JHL, de Souza LC, Andrade A. Effects of resistance training on the physical symptoms and functional capacity of patients with fibromyalgia: a systematic review and meta-analysis of randomized clinical trials. Ir J Med Sci. 2023 Aug;192(4):2001-2014. doi: 10.1007/s11845-022-03205-5. Epub 2022 Nov 3. PubMed 36326999 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2024 to primary completion in Dec 2025, 17 months.

Of 439 non-industry interventional studies with no phase under Fibromyalgia, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's 17 months is above that.

Counting every sponsor, half of 452 studies reached it within 15 months; a quarter within 6 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 21, 2026
First posted
Jul 29, 2026
StartActual
Jul 1, 2024
Primary completionActual
Dec 1, 2025
CompletionActual
Dec 15, 2025
Last update
Jul 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07734662
Lead sponsor
University of the State of Santa Catarina
Responsible party
Loiane Cristina de Souza (Researcher and Doctoral Student, University of the State of Santa Catarina) — Principal investigator
First posted
Jul 29, 2026
Start date
Jul 1, 2024
Primary completion
Dec 1, 2025
Completion
Dec 15, 2025
Last update
Jul 29, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion